Seroprevalence of HIV/HBV Coinfection in Malian Blood Donors

Abstract

Objectives. A cross-sectional study was conducted to assess the prevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and their coinfection among blood donors at the National Blood Transfusion Center in Bamako, Mali, from November 2001 to July 2002. Methods. Enzyme-linked immunosorbent assay techniques with reagents from Bio-Rad (France) were used to test the blood samples. Results. 11 592 blood donors were tested for HIV and HBV surface antigens. The prevalence of HIV was 4.5% and the prevalence of HBV was 14.9%. The HIV/HBV coinfection rate was only 1.13% in this population. Conclusion. The coinfection rate was unexpectedly low in this blood donor population where monoinfection with HIV or HBV prevalence was high.

Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients

“…Our study results confirm the high prevalence of HBV infection among HIV patients in Côte d'Ivoire, and more generally in sub-Saharan Africa, as evidenced by most studies on the subject [10,13,[15][16][17][18][19][20][21][22] . Indeed, the prevalence of HBsAg and that of anti-HBcAb were respectively 13.4% and 72.9% in our patients.…”

Prevalence of the Surface Antigen of Hepatitis B Virus among Youth Aged 15 to 24 in TOGO in 2010

“…This difference could be due to local epidemiology including contamination at a very early age in life. These results confirm the literature data showing high prevalence rates (8-20%) in Black Africa [27][28][29] and low rates in the Maghreb [30,31].…”

Seroprevalence of Hepatitis B among Blood Donors in Mbuji-Mayi, “Case of Dipumba General Hospital” (DRC)

“…Tounkara A., Sarro Y.S. and Kristensen S. report that despite progress in the fight against human immunodeficiency virus (HIV) and hepatitis B (HBV) and C (HCV) viruses, these pandemics continue to be a problem that deserves special attention in sub-Saharan Africa, which remains the most affected region of the world [2].…”